- Home
- BCAB vs IDAI Comparison
BCAB vs IDAI Comparison
Compare BCAB & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | IDAI |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 12.5M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BCAB | IDAI |
|---|---|---|
| Price | $0.15 | $2.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.3M | 57.3K |
| Earning Date | 05-05-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.19 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | N/A | $3.46 |
| Revenue Next Year | N/A | $99.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $1.43 |
| 52 Week High | $1.43 | $5.28 |
Technical Indicators
Market Signals| Indicator | BCAB | IDAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 45.91 |
| Support Level | $0.13 | $2.35 |
| Resistance Level | $0.21 | $2.82 |
| Average True Range (ATR) | 0.02 | 0.23 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 1.82 | 58.49 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.